References/Publications for Western/Immunoblot of Phl p 7

Check all              

Select PubMed ID Description
15100313 J Immunol. 2004 May 1;172(9):5684-92.

Generation of an allergy vaccine by disruption of the three-dimensional structure
of the cross-reactive calcium-binding allergen, Phl p 7.

Westritschnig K(1), Focke M, Verdino P, Goessler W, Keller W, Twardosz A, Mari A,
Horak F, Wiedermann U, Hartl A, Thalhamer J, Sperr WR, Valent P, Valenta R.


18289680 Mol Immunol. 2008 May;45(9):2465-73. doi: 10.1016/j.molimm.2008.01.009. Epub 2008
Mar 4.

Isolation, expression and immunological characterization of a calcium-binding
protein from Parietaria pollen.

Bonura A(1), Gulino L, Trapani A, Di Felice G, Tinghino R, Amoroso S, Geraci D,
Valenta R, Westritschnig K, Scala E, Mari A, Colombo P.


18564332 Clin Exp Allergy. 2008 Aug;38(8):1400-8. doi: 10.1111/j.1365-2222.2008.03031.x.
Epub 2008 Jun 28.

Heterogeneity of commercial timothy grass pollen extracts.

Focke M(1), Marth K, Flicker S, Valenta R.


20817878 J Immunol. 2010 Oct 1;185(7):4199-205. doi: 10.4049/jimmunol.0902249. Epub 2010
Sep 3.

A protein's conformational stability is an immunologically dominant factor:
evidence that free-energy barriers for protein unfolding limit the immunogenicity
of foreign proteins.

Ohkuri T(1), Nagatomo S, Oda K, So T, Imoto T, Ueda T.


27238577 Ann Allergy Asthma Immunol. 2016 Aug;117(2):180-5. doi:
1016/j.anai.2016.05.010. Epub 2016 May 27.

Detection of pan-allergens in commercial pollen extracts for allergen
immunotherapy.

Asero R(1), Mistrello G(2), Amato S(2).


31127132 Sci Rep. 2019 May 24;9(1):7802. doi: 10.1038/s41598-019-44208-0.

Rational design of a hypoallergenic Phl p 7 variant for immunotherapy of
polcalcin-sensitized patients.

Raith M(1), Zach D(1), Sonnleitner L(2), Woroszylo K(1), Focke-Tejkl M(3), Wank
H(1), Graf T(4), Kuehn A(4), Pascal M(5), Muņoz-Cano RM(6), Wortmann J(7),
Aschauer P(7), Keller W(7), Braeuer S(8), Goessler W(8), Swoboda I(9).


32375962 Allergy Asthma Proc. 2020 May 1;41(3):183-191. doi: 10.2500/aap.2020.41.200002.

Serum immunoglobulin E reactivity to cross-reacting panallergen components in
north-eastern Poland patients pollen sensitized.

Kowal K(1), Pampuch A(2), Sacharzewska E(1), Swiebocka E(3), Siergiejko Z(4),
Siergiejko G(5), Chruszcz M(6), DuBuske L(7).